These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 24511004)

  • 1. Expression of Ets-1 in human clear cell renal cell carcinomas: implications for angiogenesis.
    Mikami S; Oya M; Mizuno R; Murai M; Mukai M; Okada Y
    Cancer Sci; 2006 Sep; 97(9):875-82. PubMed ID: 16856880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma.
    Kaneko Y; Masuda T; Takamatsu K; Mikami S; Nakamura K; Nishihara H; Mizuno R; Tanaka N; Oya M
    J Pathol Clin Res; 2024 Jul; 10(4):e12388. PubMed ID: 38923836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms and clinical relevance of endothelial cell cross-talk in clear cell renal cell carcinoma.
    Sjöberg E
    Ups J Med Sci; 2024; 129():. PubMed ID: 38863726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound localization microscopy of renal tumor xenografts in chicken embryo is correlated to hypoxia.
    Lowerison MR; Huang C; Lucien F; Chen S; Song P
    Sci Rep; 2020 Feb; 10(1):2478. PubMed ID: 32051485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of insulin-like growth factor family genes in clear cell renal cell carcinoma.
    Braczkowski R; Białożyt M; Plato M; Mazurek U; Braczkowska B
    Contemp Oncol (Pozn); 2016; 20(2):130-6. PubMed ID: 27358591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGI downregulation is correlated with nodal metastasis and poor prognosis in lung adenocarcinoma.
    Xu Y; Liu Z; Li H; Feng S; Li Q; Li J; Li S
    Mol Clin Oncol; 2021 Feb; 14(2):25. PubMed ID: 33335733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression level of ASK1-interacting protein-1 correlated with tumor angiogenesis and poor survival in patients with esophageal squamous cell cancer.
    Sun D; Chen C; Hu W; Zhong C; Fan L; Song X; Gai Z
    Onco Targets Ther; 2018; 11():7699-7707. PubMed ID: 30464518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma.
    Hu JM; Liu K; Liu JH; Jiang XL; Wang XL; Chen YZ; Li SG; Zou H; Pang LJ; Liu CX; Cui XB; Yang L; Zhao J; Shen XH; Jiang JF; Liang WH; Yuan XL; Li F
    Oncotarget; 2017 Mar; 8(13):21526-21538. PubMed ID: 28423526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study about the association between vascular endothelial growth inhibitor gene polymorphisms and breast cancer risk in female patients in Northeast China.
    Han S; Liu L; Xu F; Chen S; Yuan W; Fu Z; Li D; Li D
    Chin J Cancer Res; 2016 Aug; 28(4):435-43. PubMed ID: 27647972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular density and immunohistochemical expression of VEGF, VEGFR-1 and VEGFR-2 in benign prostatic hyperplasia, high-grade prostate intraepithelial neoplasia and prostate cancer.
    Grivas N; Goussia A; Stefanou D; Giannakis D
    Cent European J Urol; 2016; 69(1):63-71. PubMed ID: 27123329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vascular endothelial growth factor-C expression on lymph node metastasis in human cholangiocarcinoma.
    Zhao R; Chang Y; Liu Z; Liu Y; Guo S; Yu J; Wang J
    Oncol Lett; 2015 Aug; 10(2):1011-1015. PubMed ID: 26622616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and role of vascular endothelial growth inhibitor in sporadic clear cell renal cell carcinoma].
    Wu LY; Cheng H; Deng XH; Shan H; Wang W; Yang Y; Zhang XD; Zhang N
    Zhonghua Yi Xue Za Zhi; 2013 Mar; 93(10):741-5. PubMed ID: 23755810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].
    Chang BD; Cao LS; Zhou HL
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complexity of tumor vasculature in clear cell renal cell carcinoma.
    Qian CN; Huang D; Wondergem B; Teh BT
    Cancer; 2009 May; 115(10 Suppl):2282-9. PubMed ID: 19402071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive biomarkers in renal cell cancer: insights in drug resistance mechanisms.
    van der Mijn JC; Mier JW; Broxterman HJ; Verheul HM
    Drug Resist Updat; 2014; 17(4-6):77-88. PubMed ID: 25457974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth inhibitor 174 is a negative regulator of aggressiveness and microvascular density in human clear cell renal cell carcinoma.
    Wu L; Li X; Ye L; Shayiremu D; Deng X; Zhang X; Jiang W; Yang Y; Gong K; Zhang N
    Anticancer Res; 2014 Feb; 34(2):715-22. PubMed ID: 24511004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential expression of vascular endothelial growth inhibitor isoforms, VEGI251, VEGI174 and VEGI192 in human clear-cell renal cell carcinoma.
    Zhang N; Wu P; Wu L; Shayiremu D; Shan H; Ye L; Jiang WG; Gong K; Yang Y
    Cancer Genomics Proteomics; 2013; 10(1):47-53. PubMed ID: 23382586
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.